Sign In
Buy APM
$1.09
+0.114 (+11.68%)
At Close: Jun 03, 2026
Andean Precious Metals: Record-High Gold-Silver Prices Pave The Way For A Mid-Tier Producer
05:43am, Tuesday, 23'rd Sep 2025
Andean Precious Metals Corp. (APM:CA) is rated a Buy, driven by strong financials and robust growth strategies in gold and silver production. APM:CA benefits from rising precious metal prices, solid f
Aptorum Group and DiamiR Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Friday, 05'th Sep 2025
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical compan
Why Is Nano-Cap Aptorum Stock Rallying On Thursday?
11:39am, Thursday, 21'st Aug 2025
Aptorum shares trade higher on 168.16 million volume vs 3.25 million average. DiamiR gains CLEP approval for APOE Genotyping test in New York.
DiamiR Biosciences and Aptorum Group Announce New York State Approval for DiamiR's APOE Genotyping Test
07:07am, Thursday, 21'st Aug 2025
NEW YORK, NY, NEW HAVEN, CT, and PRINCETON, N.J., Aug. 21, 2025 (GLOBE NEWSWIRE) -- DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and
Andean Precious Metals Corp. (ANPMF) Q2 2025 Earnings Call Transcript
12:13pm, Wednesday, 13'th Aug 2025
Andean Precious Metals Corp. (OTCQX:ANPMF) Q2 2025 Earnings Conference Call August 13, 2025 9:00 AM ET Company Participants Alberto Morales - Founder, CEO & Executive Chairman Amanda Mallough - Corpor
Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement
08:15am, Monday, 04'th Aug 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing un
Aptorum Group Limited and DiamiR Biosciences Enter into Definitive Merger Agreement
08:38am, Wednesday, 16'th Jul 2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group," “Aptorum” or the "Company"), a clinical stage biopharmaceutical company dedicated to addressing un
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
12:27pm, Wednesday, 16'th Apr 2025
Hong Kong, April 16, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM), a leading Biotechnology company, today announced that it has received a notification from the Nasdaq Stock Market LLC
CPKC and Lanco Group/Mi-Jack sell Panama Canal Railway Company to APM Terminals
08:00am, Wednesday, 02'nd Apr 2025
CALGARY, AB , April 2, 2025 /PRNewswire/ - Canadian Pacific Kansas City Limited (TSX: CP) (NYSE: CP) (CPKC) today said CPKC and the Lanco Group/Mi-Jack have sold the Panama Canal Railway Company (PCRC
Andean Precious Metals Corp. (APM) Opens the Market
11:09am, Thursday, 09'th Jan 2025
Toronto, Ontario--(Newsfile Corp. - January 9, 2025) - Alberto Morales, Executive Chairman and Chief Executive Officer, Andean Precious Metals Corp. ("Andean Precious Metals" or the "Company") (TSX: A
Synology Launches ActiveProtect: Simplifying Enterprise Data Protection with Unmatched Security, and Scalability
11:30am, Wednesday, 08'th Jan 2025
BELLEVUE, Wash.--(BUSINESS WIRE)--Synology launches the ActiveProtect series a unified enterprise backup solution set to disrupt the current data backup market.
Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering
10:55am, Thursday, 02'nd Jan 2025
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2024
04:00pm, Friday, 20'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group” or the “Company”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncolo
Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update
09:15am, Tuesday, 30'th Apr 2024
NEW YORK & LONDON--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “We”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncolo
5 Investors Betting Big on Aptorum (APM) Group
02:38pm, Wednesday, 06'th Mar 2024
Clinical-stage biopharmaceutical firm Aptorum (NASDAQ: APM ) is seeing its market value rise dramatically today on a merger between its wholly owned subsidiary and an artificial intelligence (AI) and
